Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
ImmunityBio, Inc. - Common Stock
(NQ:
IBRX
)
2.620
-0.050 (-1.87%)
Streaming Delayed Price
Updated: 4:00 PM EST, Dec 20, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
7,886,462
Open
2.660
Bid (Size)
2.640 (10)
Ask (Size)
2.650 (3)
Prev. Close
2.670
Today's Range
2.610 - 2.707
52wk Range
2.610 - 10.53
Shares Outstanding
391,156,513
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
D. Boral Capital Served as Co-Manager to ImmunityBio, Inc. (Nasdaq: IBRX) in connection with its $100.0 Million Underwritten Public Offering
December 12, 2024
From
D. Boral Capital
Via
GlobeNewswire
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
December 11, 2024
Via
Benzinga
Performance
YTD
-50.00%
-50.00%
1 Month
-48.63%
-48.63%
3 Month
-23.84%
-23.84%
6 Month
-64.31%
-64.31%
1 Year
-43.53%
-43.53%
More News
Read More
What's Going On With ImmunityBio Shares Wednesday?
December 11, 2024
Via
Benzinga
Macy's, Dave & Buster's, Bausch + Lomb And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
December 11, 2024
Via
Benzinga
Top 2 Health Care Stocks That May Fall Off A Cliff This Month
October 25, 2024
Via
Benzinga
ImmunityBio, Inc. Announces Pricing of Public Offering of Common Stock
December 11, 2024
From
ImmunityBio, Inc.
Via
Business Wire
Why Stitch Fix Shares Are Trading Higher By Around 21%; Here Are 20 Stocks Moving Premarket
December 11, 2024
Via
Benzinga
ImmunityBio, Inc. Announces Proposed Public Offering of Common Stock
December 10, 2024
From
ImmunityBio, Inc.
Via
Business Wire
10 Health Care Stocks With Whale Alerts In Today's Session
November 29, 2024
Via
Benzinga
ImmunityBio Completes ANKTIVA’s Post-Approval Enrollment of the 100th Patient in BCG Unresponsive NMIBC CIS Trial and Reports a Complete Response Rate of 71% with a Durable Duration of Response Ranging Up to 54 Months
November 19, 2024
From
ImmunityBio, Inc.
Via
Business Wire
ImmunityBio Reports Third-Quarter 2024 Financial Results
November 12, 2024
From
ImmunityBio, Inc.
Via
Business Wire
IMMUNITYBIO ALERT: Bragar Eagel & Squire, P.C. is Investigating ImmunityBio, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
October 30, 2024
From
Bragar Eagel & Squire
Via
GlobeNewswire
PROCEPT BioRobotics Posts Strong Q3 Earnings, Joins Monte Rosa Therapeutics, EyePoint Pharmaceuticals And Other Big Stocks Moving Higher On Monday
October 28, 2024
Via
Benzinga
Why LENZ Therapeutics Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket
October 28, 2024
Via
Benzinga
Trump Media & Tech, ImmunityBio, And iRhythm Are Among Top 10 Mid Cap Gainers Last Week (Oct 21-Oct 25): Are The Others In Your Portfolio?
October 27, 2024
Via
Benzinga
Topics
Government
Exposures
Political
Jeff Bezos Ends Washington Post's 36-Year Tradition Of Endorsements, Leaving Staff 'Roiled'
October 25, 2024
Via
Benzinga
Booz Allen Posts Upbeat Q3 Earnings, Joins Deckers Outdoor, Saia, Boyd Gaming And Other Big Stocks Moving Higher On Friday
October 25, 2024
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
October 25, 2024
Via
Benzinga
Why Deckers Outdoor Shares Are Trading Higher By Around 14%; Here Are 20 Stocks Moving Premarket
October 25, 2024
Via
Benzinga
First Patients Dosed in Phase 1 Clinical Study of ImmunityBio’s CAR-NK Cell Therapy for the Treatment of Relapsed B-Cell Non-Hodgkin Lymphoma
October 24, 2024
From
ImmunityBio, Inc.
Via
Business Wire
800% Upside For This Biotech Stock - Analyst Initiates Coverage On Bladder Cancer Focused ImmunityBio
October 23, 2024
Via
Benzinga
Texas Instruments Posts Strong Q3 Results, Joins Valmont Industries, Lithia Motors, Teledyne Technologies And Other Big Stocks Moving Higher On Wednesday
October 23, 2024
Via
Benzinga
ImmunityBio to Participate in the Jefferies London Healthcare Conference
October 21, 2024
From
ImmunityBio, Inc.
Via
Business Wire
Why Champions Oncology Shares Are Trading Higher By Over 13%; Here Are 20 Stocks Moving Premarket
September 12, 2024
Via
Benzinga
Terns Pharmaceuticals, Boeing, Tesla And Other Big Stocks Moving Higher On Monday
September 09, 2024
Via
Benzinga
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.